Edited by
Bruce Baguley, The University of Auckland, New Zealand
David Kerr, University of Oxford, United Kingdom
Description
Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary
fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction,
the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical
trial design are also provided.
Audience:
Oncologists, cancer researchers, pharmacologists, molecular biologists, and cell biologists.
